Vipul Garg
Department of Community Medicine, Jawaharlal Nehru Medical College, Datta Meghe Institute of Medical Sciences (Deemed to be University), Sawangi (Meghe), Wardha, Maharashtra, IndiaPublications
-
Review Article
COVID-19 IN HIGH RISK COMORBID PATIENTS.
Author(s): Vipul Garg and Swaroopa Chakole*
Since December 2019, the on-going epidemic, COVID-19, also known as severe acute respiratory syndrome CoV-2, has infected over 70 lakh people throughout the globe. Coronavirus are a broad group of viruses that can cause a variety of lung diseases in human beings, from mild to severe. CoV-2 or severe acute respiratory syndrome, is an infective and pathogenic Coronavirus that first appeared towards the end of 2019 and has subsequently produced a pandemic of acute respiratory illness known as "Coronavirus disease 2019", which is a global health issues. Its complaints can vary from a simple cough to more extreme disorders like bronchitis, pneumonia, ARDS, MODS and can be fatal. COVID-19 is known to have rapid and serious advancement in those with already existing health issues, often resulting to death. Individuals with prior history of morbidities, like dia.. Read More»